Toray Of Japan, University Develop Insulin Nasal Spray For Diabetes
This article was originally published in PharmAsia News
Japan's Toray Industries and a university disclosed they have developed an insulin for diabetics that can be administered through a nasal spray. Toray and Hoshi University said their method combines a peptide with insulin to form a liquid that can be delivered in spray form. The method, if proven successful, would substitute for diabetic reliance on regular insulin injections. Testing of the method in mice, according to researchers, showed that 50 percent of the insulin administered in that manner enters the blood to help lower blood sugar levels. The team plans to begin clinical trials to prove the method is efficacious and safe in humans. (Click here for more - a subscription may be required
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.